20 years of research found that it can prolong the life expectancy of diabetic patients for up to 8 years September 28, 2016 Source: WuXi PharmaTech Diabetes, how can you live longer and live better? Recently, European scientists have found that focusing on the comprehensive management of patients in the early stage can extend the life expectancy of elderly patients with type 2 diabetes for 8 years, and there are no serious complications during the life span. This will motivate the field of diabetes research to shift to the strategy of “ageing for health and prolonging lifeâ€. The relevant research results were published in the official journal Diabetologia of the European Diabetes Research Society. Diabetes is a series of health problems caused by disorders of glucose metabolism in the human body. It is a chronic disease that affects hundreds of millions of people around the world, and the incidence rate is increasing year by year. According to WHO statistics, there are more than 400 million diabetic patients worldwide, and the number of patients is expected to rise to 642 million by 2040. If it is not effectively controlled, the harm of diabetes is very serious, which can further lead to serious diseases such as heart disease, stroke, retinopathy, renal failure, foot neuropathy and amputation. Diabetes treatments can include diet, exercise, medications, etc., which are the focus of frequent attention in the field of diabetes research. However, people with diabetes may have experienced this experience: even after the above methods have been tried, they have not reached the expected level of efficacy. It seems that in addition to treatment, the timing and strategy of treatment of diabetes is also very important. In the study, scientists evaluated how early comprehensive management of patients' strategies would affect the lifespan and quality of life of diabetic patients. The study included 160 patients with type 2 diabetes mellitus from Denmark who had a small amount of proteinuria. The average age at the start of the study was 55 years old, and they were all overweight. These patients were randomized into two groups, one group was routinely treated; the other group was comprehensively managed for all risk factors that may lead to complications or death, such as reasonable hypoglycemic, antihypertensive, lipid-lowering, and thromboembolic prevention. Treatment, as well as behavioral habit correction (such as healthy eating, exercise changes, helping to quit smoking). This research lasted for 20 years. The results showed that patients in the intensive management group lived an average of 8 years longer than the conventional treatment group, and the time to heart attack and stroke was delayed by an average of 8 years. Among them, those who use statins to reduce fat, the benefits are relatively more obvious. "For patients with type 2 diabetes, early intervention with intensive microalbuminuria, including early treatment and behavioral correction, will not only allow the patient to live longer, but also during the extended lifespan. Terrible serious complications," said Professor Oluf Pedersen, the author of the study. He is a physician and endocrinologist at the Novo Nordisk Foundation in Copenhagen, Denmark. Dr. Pedersen explained that the presence of microalbuminuria in diabetic patients may be a precursor to other complications, as microalbuminuria often suggests kidney damage or a sign of systemic vascular injury. At this point, an all-round multi-tube intensive treatment can control the regulatory risk factors known to be associated with complications or premature death, including blood glucose, blood pressure, cholesterol and triglyceride levels, and the risk of thrombosis. Dr. Joel Zonszein, Director of the Clinical Diabetes Center at the Montefiore Medical Center in New York, commented: “These results are impressive and the key information they contain is very instructive. Currently, regarding the concept of diabetes treatment, we I did not emphasize the need to adopt an all-round multi-pronged intensive treatment strategy from the outset, and did not emphasize compliance treatment at the outset." Peru Squid ,Peru Jumbo Flying Squid,Peru jumbo flying squid Zhoushan Boda Aquatic Products Co.,Ltd , https://www.baida-aquatic.com